NCT06699732 Impact of Mindful Self-Compassion Therapy on Self Harm Behaviors, Emotional Regulation and Quality of Life Among Patients With Borderline Personality Disorder
| NCT ID | NCT06699732 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fatima Jinnah Women University |
| Condition | Psychological Distress |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-09-21 |
| Primary Completion | 2025-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-09-21 with a primary completion date of 2025-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary purpose of the study is to investigate whether Mindful Self-Compassion (MSC) therapy can significantly reduce self-harm behaviors, improve emotional regulation, and enhance the quality of life in individuals diagnosed with Borderline Personality Disorder (BPD). The study aims to contribute to the existing literature by providing robust evidence on the efficacy of MSC therapy for BPD, which could inform clinical practices and improve treatment outcomes
Eligibility Criteria
Inclusion Criteria: * 1\. First time diagnosed non-hospitalized patients of Borderline Personality Disorder. 2\. Patients of Borderline Personality Disorder experiencing psychological distress,low level of quality of life, social support, emotional dysregulation would be included. 3\. Borderline Personality Disorder patients with age 18 years and above (both gender) from outpatient department (OPD) 4. Borderline personality patients who would be able to understand Urdu language and can give the informed consent * Exclusion criteria The study would have the following exclusion criteria: 1. Hospitalized patients of Borderline Personality 2. Patients with Borderline Personality having other chronic co-morbid diseases such as cancer, cognitive deficits, and other chronic psychological disorders. 3. Patients with Borderline Personality younger than 18 years of age
Contact & Investigator
Asma Mansoor, PhD Scholar
PRINCIPAL INVESTIGATOR
Fatima Jinnah Women University, Rawalpindi, Pakistan
Frequently Asked Questions
Who can join the NCT06699732 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Psychological Distress. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06699732 currently recruiting?
Yes, NCT06699732 is actively recruiting participants. Contact the research team at asmansoor31@yahoo.com for enrollment information.
Where is the NCT06699732 trial being conducted?
This trial is being conducted at Rawalpindi, Pakistan, Rawalpindi, Pakistan.
Who is sponsoring the NCT06699732 clinical trial?
NCT06699732 is sponsored by Fatima Jinnah Women University. The principal investigator is Asma Mansoor, PhD Scholar at Fatima Jinnah Women University, Rawalpindi, Pakistan. The trial plans to enroll 60 participants.